Skip to main content
Schroders PLC logo

Schroders PLC — Investor Relations & Filings

Ticker · SDR ISIN · GB00BP9LHF23 LEI · 2138001YYBULX5SZ2H24 IL Financial and insurance activities
Open in API
Filings indexed 7,579 across all filing types
Latest filing 2025-03-27 Major Shareholding Noti…
Country GB United Kingdom
Listing IL SDR

About Schroders PLC

https://www.schroders.com/

Schroders PLC is a global asset and wealth management company. It serves a diverse international clientele, including institutions, financial intermediaries, high-net-worth individuals, and family offices. The firm provides a broad range of actively managed investment solutions that span both public and private markets. Key business areas include comprehensive wealth management services, delivered through brands such as Cazenove Capital, and specialized private asset management, including renewable infrastructure investments. The company leverages its global platform and expertise to help clients achieve their financial goals.

Recent filings

Filing Released Lang Actions
Form 8.3 - TI Fluid Systems PLC
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offer (in this case, related to TI Fluid Systems PLC). This type of disclosure, mandated by the UK Takeover Code, relates to insider dealings or significant position changes during a takeover scenario. While it involves director/insider activity, the specific context of a takeover bid and the Form 8.3 structure strongly align with regulatory filings related to transactions, but it is most specifically captured under the general 'Regulatory Filings' (RNS) category as it is a mandatory disclosure to the Regulatory Information Service (RNS) concerning takeover activity, which is not explicitly covered by DIRS (Director's Dealing, which is usually Form 3/4 equivalent) or TAR (M&A Activity, which is usually the bid announcement itself). Given the options, RNS is the most appropriate general regulatory filing category for a specific, non-standard disclosure form like Form 8.3, although it is closely related to insider activity. However, since it details personal share transactions by a party involved in an offer, it is a specific type of insider disclosure. Since 'Director's Dealing' (DIRS) is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this is an insider trade disclosure related to a takeover, DIRS is a strong candidate, but Form 8.3 is highly specific to takeover rules, not general insider trading. Given the structure and mandatory nature of reporting to RNS regarding takeover rules, RNS is the safest fit if DIRS is interpreted strictly as routine insider trading outside of a formal offer context. Let's re-evaluate: Form 8.3 is a mandatory disclosure of interests/dealings during a takeover. This is a regulatory filing (RNS). It is also a dealing disclosure (DIRS). Since the document is a formal, structured filing (Form 8.3) published via RNS, and it details dealings, we must choose the best fit. DIRS covers 'insider trades'. Form 8.3 is an insider trade disclosure during a takeover. Given the specific nature of the form and its publication via RNS, RNS serves as the best general regulatory category for non-standard, mandatory disclosures like this, unless a more specific category exists. Since DIRS is for general director dealing, and this is takeover-related dealing, RNS is the most accurate fallback for this specific regulatory form.
2025-03-27 English
Form 8.3 - Primary Health Properties PLC
Regulatory Filings Classification · 95% confidence The document explicitly states it is a 'FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This form relates to disclosures required during a takeover or merger activity involving 'Primary Health Properties Inc' and 'Assura plc'. This specific type of disclosure, dealing with interests in securities during a takeover, is a specialized regulatory filing related to M&A activity. While it is a regulatory filing, the most specific category covering takeover-related disclosures of share interests is related to M&A activity (TAR) or general regulatory filings (RNS). Since 'FORM 8.3' is a specific disclosure required under the Takeover Code, and the document details positions and dealings related to an offer, it strongly aligns with the context of M&A activity. However, looking at the provided codes, there isn't a specific code for 'Takeover Disclosure Form 8.3'. The closest relevant categories are TAR (M&A Activity) or RNS (General Regulatory Filings). Given that this is a mandatory disclosure related to a potential takeover/merger (indicated by the reference to the Takeover Code and parties involved), TAR is a strong candidate. However, Form 8.3 is a standard disclosure required by the Takeover Panel, which often falls under general regulatory announcements if a specific M&A form isn't available. Since the document is a formal disclosure mandated by a regulatory body (The Panel) and distributed via RNS, and it details insider/significant shareholder activity during a potential M&A event, classifying it as a general Regulatory Filing (RNS) is the safest and most encompassing fit among the provided options, as it is not the M&A announcement itself (TAR) but a subsequent required disclosure. Given the structure and distribution via RNS, RNS is the most appropriate fallback for specific, non-core report regulatory forms.
2025-03-27 English
Form 8.3 - Direct Line Insurance Group Plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' related to an offer involving 'Direct Line Insurance Group plc' and 'Aviva Plc'. This type of mandatory disclosure concerning interests in securities during a takeover/merger process is a specific regulatory filing related to M&A activity. While it relates to a takeover (TAR), the specific nature of this form (Rule 8.3 disclosure) is a mandatory regulatory filing disseminated via RNS. Since the definitions do not have a specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory announcement disseminated through the RNS system, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that doesn't fit the other specific categories like ER, 10-K, or DIV. It is not a general M&A announcement (TAR) but a specific disclosure required during the M&A process.
2025-03-27 English
Form 8.3 - Aviva Plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code (the "Code")'. This form is a mandatory disclosure related to takeover activity, detailing a party's interest (Schroders plc) in the securities of an offeror/offeree (Aviva plc). This type of specific regulatory filing concerning takeover rules and insider/significant holdings is best categorized under filings related to corporate actions or regulatory disclosures. Since there is a specific category for Director's Dealing (DIRS) and Major Shareholding Notification (MRQ), but this is specifically tied to a takeover context (Rule 8.3), it falls under the general regulatory announcement category, which is RNS, as it is a mandatory disclosure disseminated via RNS (London Stock Exchange news service). It is not a general earnings release (ER), an annual report (10-K), or a proxy statement (PSI). Given the context of mandatory disclosure under the Takeover Code disseminated via RNS, RNS is the most appropriate general regulatory filing code.
2025-03-27 English
Form 8.3 - Assura Plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code'. This form is a mandatory disclosure related to takeover activity, specifically detailing shareholdings and dealings in the context of an offer (Assura plc and Primary Health Properties Plc are mentioned). This type of filing, which reports insider/significant shareholder activity during a takeover process, does not fit neatly into the standard financial report categories (10-K, IR, ER). It is a specific regulatory filing related to corporate actions/takeovers. Since there is no specific code for 'Takeover Disclosure Form 8.3', the most appropriate general category for mandatory regulatory disclosures that don't fit elsewhere is 'Regulatory Filings' (RNS). However, given the context of the Takeover Code, it is a highly specific regulatory disclosure. Reviewing the provided codes, 'RNS' (Regulatory Filings) is the best fit as a catch-all for mandatory regulatory announcements not covered by other specific codes like DIV or DIRS. The document is a formal disclosure required by the Takeover Panel, disseminated via RNS.
2025-03-27 English
Form 8.3 - Assura PLC
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and concerns a 'PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This form relates to interests and dealings during a takeover situation involving Assura plc and Primary Health Properties Plc. This type of disclosure, mandated by the UK Takeover Code, is a specific regulatory filing concerning insider/major shareholder activity during a bid. While it relates to director/insider dealings (DIRS) and major shareholdings (MRQ), the specific context of a formal takeover disclosure (Form 8.3) is best captured by the general 'Regulatory Filings' category (RNS) as it is a mandatory filing to the Takeover Panel, or potentially DIRS if the focus was purely on executive trades outside a takeover context. Given the explicit reference to the Takeover Code and Form 8.3, RNS is the most appropriate general regulatory classification for this specific mandatory disclosure type that isn't covered by DIRS (which usually refers to standard insider transaction reports like Form 3/4/5 or DTR 3 filings, not takeover code disclosures). However, since the content is fundamentally about director/insider dealing in the context of a takeover, and DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)', this is a strong candidate. Let's re-evaluate the options: DIRS is for insider trades. This is an insider trade disclosure related to a takeover. MRQ is for major shareholding notifications (crossing thresholds). This disclosure reports a 5.458% holding and a sale, which is a major holding change. Given the structure and the explicit mention of 'Director's Dealing' (DIRS) covering 'insider trades', and this being a mandatory disclosure of a significant position/dealing by a major shareholder (Schroders plc) during a takeover process, RNS (General Regulatory Filings) is the safest catch-all for specific, non-standard regulatory forms like Form 8.3, unless DIRS is interpreted broadly to include all insider/major shareholder disclosures. Since Form 8.3 is a specific regulatory filing related to a takeover, RNS is the most accurate fit among the provided options for a non-standard, mandatory regulatory announcement.
2025-03-26 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.